Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,302 | -238,286 | -189,217 | -130,224 | -74,822 |
| Depreciation Amortization | 922 | 3,398 | 2,472 | 1,702 | 846 |
| Accounts receivable | N/A | 1,859 | 1,859 | 1,859 | 1,833 |
| Accounts payable and accrued liabilities | -1,267 | -4,454 | -10,070 | -4,315 | -6,033 |
| Other Working Capital | 554 | -5,133 | -7,257 | -15,131 | -7,827 |
| Other Operating Activity | 10,509 | 42,330 | 31,849 | 17,258 | 12,726 |
| Operating Cash Flow | $-33,584 | $-200,286 | $-170,364 | $-128,851 | $-73,277 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -81 | -4,573 | -4,464 | -2,652 | -1,691 |
| Purchase Of Investment | -13,100 | -74,344 | -74,344 | -59,862 | -49,887 |
| Sale Of Investment | N/A | 74,500 | 60,000 | 15,000 | N/A |
| Investing Cash Flow | $-13,181 | $-4,417 | $-18,808 | $-47,514 | $-51,578 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 225 | 482 | 200,310 | 125,211 | 125,131 |
| Other Financing Activity | 1,653 | 206,305 | -415 | -398 | -134 |
| Financing Cash Flow | $1,878 | $206,787 | $199,895 | $124,813 | $124,997 |
| Exchange Rate Effect | -13 | -120 | -113 | -43 | -165 |
| Beginning Cash Position | 127,756 | 125,792 | 125,792 | 125,792 | 125,792 |
| End Cash Position | 82,856 | 127,756 | 136,402 | 74,197 | 125,769 |
| Net Cash Flow | $-44,900 | $1,964 | $10,610 | $-51,595 | $-23 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,584 | -200,286 | -170,364 | -128,851 | -73,277 |
| Capital Expenditure | -81 | -4,573 | -4,464 | -2,652 | -1,691 |
| Free Cash Flow | -33,665 | -204,859 | -174,828 | -131,503 | -74,968 |